ZSAN Stock Price, News & Analysis
Company Description
ZSAN (NASDAQ: ZSAN) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $2.7M.
ZSAN stock has declined 98.3% over the past year.
This page provides a comprehensive overview of ZSAN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ZSAN (ZSAN) stock. Over the past 12 months, the stock has lost 98.3%. At a market capitalization of $2.7M, ZSAN is classified as a micro-cap stock with approximately 4.9M shares outstanding.
Latest News
ZSAN has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include earnings, stock split, offering, clinical trial, management. View all ZSAN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ZSAN Company Profile & Sector Positioning
ZSAN (ZSAN) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing ZSAN often look at related companies in the same sector, including Lipella Pharmaceuticals Inc (LIPO), Salarius Pharmaceuticals Inc (SLRX), Gt Biopharma Inc (GTBP), Protagenic Therapeutics Inc (PTIX), and Virax Biolabs Group Ltd (VRAX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ZSAN's relative position within its industry.